“Trastuzumab in the Second-Line Treatment of HER2-Positive Metastatic Gastric Cancer. Experience of the Moscow Oncology Service”, Вопр. онкол., vol. 72, no. 2, p. OF-2514, May 2026, doi: 10.37469/0507-3758-2026-72-2-OF-2514.